Quick stats from Amgen’s 2022 #Biosimilar Trends

Quick stats from Amgen’s 2022 #Biosimilar Trends Report:

📈 39 U.S. biosimilars approved

🚀 22 U.S. biosimilars lau… https://t.co/B40DGOJrxb

😍 Crohn’s & Colitis Awareness Month Day #3

😍 Crohn’s & Colitis Awareness Month Day #3 😍 Donate For Crohns Today! https://t.co/9heJjYmsyn

I’ve ignored 99.9% of the rude comments I’ve received throughout my life. Now I just laugh, because they truly hav… https://t.co/qAcM2l8WVZ

This week in journal club, we discussed https://t.co/qzi5dGIVDD from @CadwellLab. Impressive work extending the MNV… https://t.co/IqGOWmSWvl

https://t.co/mCsXIZP9NS <—// THE MASTER’S KEY: clearing disease through the science of understanding the biologic… https://t.co/83Pehq6vjo

An IQVIA report recapped the US experience with Semglee, an #insulin glargine #biosimilar that has versions with &… https://t.co/uvvkd8Vg49

@DeClercqLuc Ik zou in dergelijk geval ook eerst bellen, voor wat het waard is. Maar gezien het EMA-advies (en FDA?… https://t.co/wr8yniVETa

Fast Facts: Biosimilars in Hematology and Oncology: Biologics and biosimilars – getting decisions right UUFYVWA… https://t.co/bAi1kJ2DQT

Save the date, for useful information around #biosimilars in Canada. #GlobalBiosimilarsWeek https://t.co/E13ZovSVOt